Montelukast Prescribing at CHURCH STREET PARTNERSHIP
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
784
Total Quantity
20.6K
NHS Cost
£1.1K
vs National Avg
+14.5%
CHURCH STREET PARTNERSHIP prescribed 784 items of Montelukast over the last 12 months at a cost of £1,083 to the NHS. This is 14.5% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
72
Jul 2026
67
Jul 2026
63
Jul 2026
63
Jul 2026
65
Jul 2026
76
Jul 2026
65
Jul 2026
58
Jul 2026
76
Jul 2026
62
Jul 2026
66
Jul 2026
51
Prescribing Details
| Total Items | 784 |
|---|---|
| Total Quantity | 20,604 |
| Total NHS Cost | £1,083 |
| Presentations | 4 different forms |
| vs National Average | +14.5% |
Montelukast Prescribing Comparison
| This practice | 784 items |
|---|---|
| National average per practice | 685 items |
| Difference | +14.5% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.